Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 31 for “"Radiochemotherapy"”.
-
18F-FDG PET/CTCT-based Radiomics for the Prediction of Radiochemotherapy Treatment Outcomes of Cervical Cancer
… cancer patients consecutively treated with radiochemotherapy. We extracted radiomic features from the primary cervical tumor volumes, and voxel intensity-based features from tumor habitats to analyze the tumors’ heterogeneity based on 18Flourodeoxyglocuse (18F-FDG) uptake of PET, and …
-
Characterization of the molecular mechanisms of resistance to radiochemotherapy of head and neck squamous cell carcinoma
Head and neck squamous cell carcinoma (HNSCC) is the sixth most common malignancy worldwide with an incidence of more than 650 000 cases per year and 330 000 cancer deaths worldwide. These tumors mainly arise in the squamous epithelium within the oral cavity, pharynx and salivary glands. Major risk …
-
Comparison of concurrent chemoradiotherapy versus sequential radiochemotherapy in patients with completely resected non-small cell lung cancer
PURPOSE: Our institution has executed two different kinds of adjuvant protocols in treating patients with non-small cell lung cancer (NSCLC): 1) chemotherapy followed by concurrent chemoradiotherapy (CTx-CCRT) and 2) sequential postoperative radiotherapy (PORT) followed by postoperative …
-
Assessment of the influence of the tumor microenvironment on the microscopic tumor extension in esophageal cancer patients
… TME biomarkers with MTE before, during or after radiochemotherapy (RCHT) is crucial in the era of image-guided, adaptive high-precision photon or particle therapy. In this thesis, two study cohorts were used to assess some selected TME biomarkers and their predictive value on MTE for an improved …
-
Discoidin Domain Receptor 1 critically regulates GBM cell survival and invasion
… role of DDR1 in GBM invasion and response to radiochemotherapy and investigates the underlying molecular mechanisms. Materials and Methods: Expression of DDR1 and GBM stem cell markers was evaluated in 13 biopsies of patients with primary GBM and correlated with overall survival. The effects …
-
Pathological and Biological Aspects of Colorectal Cancer Treatment.
… What are the crucial prognostic factors after radiochemotherapy in patients with LARC? Which markers can be used to predict therapy response in LARC patients? What is the value of thymidylate synthase genotyping and immunohistochemistry in patients with stage III colon cancer? These are a few …
-
Συσχέτιση ακτινοθεραπείας και ακτινοχημειοθεραπείας με την αποτελεσματικότητα και την ποιότητα ζωής ασθενών με καρκίνο του τραχήλου της μήτρας
… we compared the impact of radiotherapy (RAD) and radiochemotherapy (RAD/CHEM) on CC patients’ QOL. Our sample included 105 women who suffered from CC stagesIA-IIIA that were treated either with RAD or RAD/CHEM, and filled in the questionnaires 1 year after treatment completion. We used 4 …
-
FDG-PET/CT for oral focus assessment in head and neck cancer patients
… emission tomography–computed tomography; Radiochemotherapy
-
Quantification of Inter- and Intra-Tumor Heterogeneity Using Medical Imaging and Its Implication on Response to Radiotherapy in Head and Neck Cancer
… [2]. It shows a heterogeneous response to radiochemotherapy with loco-regional control and 5 years overall survival ranging from below 50% to 80%. Few molecular factors were linked to outcome prognosis in HNSCC, for example human papilloma virus (HPV) infection. However, tissue-based …
-
Long-term survival analysis of dental implants & implant-supported prostheses in patients after squamous cell carcinoma in head and neck region
… patients following ablative surgery and possible radiochemotherapy can be extremely challenging for the surgeons and prosthetists. A conventional prosthetic solution is often not feasible due to the alteration of anatomical conditions following surgical rehabilitation. In such cases, …
-
Functional assessment of the multidrug resistance phenomenon following gamma- irradiation therapy
… which are most frequently treated with combined radiochemotherapy protocols. The present work reports of significant overexpression of P-glycoprotein, MRP1 and LRP on gene and protein level following fractionated irradiation. This observation was paralleled by chemoresistance to clinically …
-
Anti-Cancer Treatment and the Cell Cycle: Cellular-Level Mathematical Models
… peak additive damage model is then applied to radiochemotherapy. Its performance is superior to the previously proposed independent cell kill model when tested with 218 data sets for fixed-schedule exposure against. For varying-schedule exposures, cell heterogeneity and cycle asynchrony …
-
Ursprung und Expansion der Klonalen Hämatopoese während der hämatopoetischen Differenzierung
… under cellular stress conditions such as radiochemotherapy. Methods: 437 patients (n = 365 and n = 72) were recruited within the main project. For mutation detection, we used a combination of targeted deep and digital droplet polymerase chain reaction (ddPCR) sequencing. Flow cytometry was …
-
CCI-779 (Temsirolimus) exhibits increased anti-tumor activity in low EGFR expressing HNSCC cell lines and is effective in cells with acquired resistance to cisplatin or cetuximab
… is still cisplatin-based concurrent radiochemotherapy. For patients who cannot tolerate cytotoxic chemotherapy, addition of the anti- epidermal growth factor receptor antibody cetuximab to radiotherapy has been the only FDA approved option since 2006. These small improvements of …
-
Molecular characterisation of tumours and biomarker identification for personalised radiation oncology using genomic data of patients with locally advanced head and neck squamous cell carcinoma
… radiotherapy (PORT) or postoperative radiochemotherapy (PORT-C) were evaluated. Data from 60 mice bearing xenografts of ten established human HNSCC cell lines were also evaluated. Gene expression analyses was performed using the GeneChip Human Transcriptome Array 2.0 and nanoString …
-
Wirksamkeit der neoadjuvanten Radiochemotherapie an der Charité Berlin bei Patienten mit Rektumkarzinom im Stadium II oder III
Einleitung und Fragestellung: Die Durchführung einer neoadjuvanten 5-FU- basierten Radiochemotherapie ist die Standardtherapie bei Rektumkarzinomen im UICC-Stadium II und III. Ziel dieser Arbeit ist es, die Wirksamkeit der Durchführung dieser Therapie an der Charité Berlin mit Ergebnissen …
-
Akut- und Spättoxizitäten im Rahmen der ARO 95-06 Studie
Diese Dissertationsarbeit befasst sich mit den beobachteten Toxizitäten der multizentrischen prospektiv randomisierten ARO 95-06 Studie, die bei 384 Patienten mit lokal fortgeschrittenen Plattenepithelkarzinomen der Kopf-Hals- Region zeigte, dass ein Therapieschema mit simultaner Radiochemotherapie …
-
Klinische Ergebnisse und Lebensqualität nach neoadjuvanter Radiochemotherapie von Rektumkarzinomen
Die derzeitige Standardtherapie bei fortgeschrittenen Rektumkarzinomen der UICC Stadien II und III besteht aus der neoadjuvanten Radio(chemo)therapie mit nachfolgender chirurgischer Intervention. Hierbei werden die beiden Therapiemodalitäten, der Kurzzeit-Radiotherapie(5x5Gy) und unmittelbare …
-
Strahlentherapeutische Strategien in der multimodalen Therapie von lokalisierten High-Grade-Weichgewebesarkomen
Hintergrund: Weichgewebesarkome (STS) sind seltene, histologisch heterogene Tumoren. Ziele dieser Arbeit waren: Publikation I: Die Rolle der neoadjuvanten Radiotherapie (RT) im Hinblick auf das Gesamtüberleben (OS), lokale Kontrolle (LC), Freiheit von Fernmetastasen (FFDM) und Toxizität bei …
Page 1 of 2